Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep-Oct;5(5):293-9.
doi: 10.4161/bioe.29935.

Tools for metabolic engineering in Streptomyces

Affiliations

Tools for metabolic engineering in Streptomyces

Valerie Bekker et al. Bioengineered. 2014 Sep-Oct.

Abstract

During the last few decades, Streptomycetes have shown to be a very important and adaptable group of bacteria for the production of various beneficial secondary metabolites. These secondary metabolites have been of great interest in academia and the pharmaceutical industries. To date, a vast variety of techniques and tools for metabolic engineering of relevant structural biosynthetic gene clusters have been developed. The main aim of this review is to summarize and discuss the published literature on tools for metabolic engineering of Streptomyces over the last decade. These strategies involve precursor engineering, structural and regulatory gene engineering, and the up or downregulation of genes, as well as genome shuffling and the use of genome scale metabolic models, which can reconstruct bacterial metabolic pathways to predict phenotypic changes and hence rationalize engineering strategies. These tools are continuously being developed to simplify the engineering strategies for this vital group of bacteria.

Keywords: Streptomycetes; genome scale metabolic models; industrial production; metabolic engineering; secondary metabolites.

PubMed Disclaimer

Figures

None
Figure 1. StreptomeDB GUI output.
None
Figure 2. Metabolic engineering of various genes in the glycolytic pathway for improved clavulanic acid production. (1) Disruption of gap genes in order to remove competing pathways and hence improve clavulanic acid production. (2) Duplication of pah2 gene encoding a proclavaminate amidino hydrolase, one of the precursors in clavulanic acid production. (3) Increasing cas2 gene production by using recombinant plasmids, which codes for clavaminate synthase gene, another precursor in clavulanic acid production.

References

    1. Hodgson DA. Primary metabolism and its control in Streptomycetes: a most unusual group of bacteria. Adv Microb Physiol. 2000;42:47–238. doi: 10.1016/S0065-2911(00)42003-5. - DOI - PubMed
    1. Hopwood DA. Soil to genomics: the Streptomyces chromosome. Annu Rev Genet. 2006;40:1–23. doi: 10.1146/annurev.genet.40.110405.090639. - DOI - PubMed
    1. Omura S, Ikeda H, Malpartida F, Kieser HM, Hopwood DA. Production of new hybrid antibiotics, mederrhodins A and B, by a genetically engineered strain. Antimicrob Agents Chemother. 1986;29:13–9. doi: 10.1128/AAC.29.1.13. - DOI - PMC - PubMed
    1. Bérdy J. Bioactive microbial metabolites. J Antibiot (Tokyo) 2005;58:1–26. doi: 10.1038/ja.2005.1. - DOI - PubMed
    1. Lucas X, Senger C, Erxleben A, Grüning BA, Döring K, Mosch J, Flemming S, Günther S. StreptomeDB: a resource for natural compounds isolated from Streptomyces species. Nucleic Acids Res. 2013;41:D1130–6. doi: 10.1093/nar/gks1253. - DOI - PMC - PubMed

Publication types

MeSH terms